That said I don't think this forum is going anywhere and turns over just like the volume with nobody really caring. I would hate to have a decent hold in this grub stock with a CR pending and early trials without patients. I wouldn't commit to reproduced stem cell therapy either given that the natural version is yet to be approved. Holders of CYP are best to jump out for the short time and invest in MSB and with success go back.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)